Skip to main content

Table 7 Association between procurement efficiency and variables that affect procurement prices

From: How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014

 

Model 7A

Model 7B

Coefficient (Standard error)

Coefficient (Standard error)

Constant

0.793

(0.124)***

0.600

(0.128)***

Procurement type

 APPL (reference group)

  National tender

0.121

(0.213)

−0.164

(0.223)

  Direct purchase

0.397

(0.141)**

0.180

(0.152)

Source and category

  Local generic (reference group)

    

  Imported originator

  

0.712

(0.205)***

  Imported generic

  

0.422

(0.136)**

Route of administration

 Oral preparation (reference group)

  Injectable drugs

−0.370

(0.160)*

− 0.415

(0.158)**

  Other preparations

−0.661

(0.199)***

−0.680

(0.210)***

Total quantity (‘000,000 DDDs)

−0.009

(0.003)**

−0.007

(0.002)**

Total expenditure (‘000,000 MYR)

0.036

(0.017)*

0.029

(0.015)

Year

 2010 (reference group)

  2011

−0.088

(0.066)

−0.044

(0.064)

  2012

−0.116

(0.074)

−0.043

(0.070)

  2013

−0.195

(0.083)*

−0.132

(0.080)

  2014

−0.200

(0.083)*

−0.114

(0.082)

Adjusted R-squared

0.096

 

0.159

 

Number of observations

1265

 

1265

 
  1. Dependent variable is the log of price ratio of MOH product procurement price relative to MSH IRP
  2. * P < 0.05; ** P < 0.01; *** P < 0.001